These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 23026082)
1. The antitumor agent doxorubicin binds to Fanconi anemia group F protein. Kusayanagi T; Tsukuda S; Shimura S; Manita D; Iwakiri K; Kamisuki S; Takakusagi Y; Takeuchi T; Kuramochi K; Nakazaki A; Sakaguchi K; Kobayashi S; Sugawara F Bioorg Med Chem; 2012 Nov; 20(21):6248-55. PubMed ID: 23026082 [TBL] [Abstract][Full Text] [Related]
2. Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia. Yao C; Du W; Chen H; Xiao S; Huang L; Chen FP Mol Med Rep; 2015 Jun; 11(6):4605-10. PubMed ID: 25647473 [TBL] [Abstract][Full Text] [Related]
3. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells. Dai CH; Li J; Chen P; Jiang HG; Wu M; Chen YC J Biomed Sci; 2015 Sep; 22(1):77. PubMed ID: 26385482 [TBL] [Abstract][Full Text] [Related]
4. FANCE: the link between Fanconi anaemia complex assembly and activity. Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA. Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709 [TBL] [Abstract][Full Text] [Related]
7. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739 [TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells. Zhao L; Li N; Yu JK; Tang HT; Li YL; He M; Yu ZJ; Bai XF; Zheng ZH; Wang EH; Wei MJ Braz J Med Biol Res; 2014 Jan; 47(1):24-34. PubMed ID: 24345874 [TBL] [Abstract][Full Text] [Related]
9. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539 [TBL] [Abstract][Full Text] [Related]
11. X-linked inheritance of Fanconi anemia complementation group B. Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827 [TBL] [Abstract][Full Text] [Related]
12. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. de Winter JP; Rooimans MA; van Der Weel L; van Berkel CG; Alon N; Bosnoyan-Collins L; de Groot J; Zhi Y; Waisfisz Q; Pronk JC; Arwert F; Mathew CG; Scheper RJ; Hoatlin ME; Buchwald M; Joenje H Nat Genet; 2000 Jan; 24(1):15-6. PubMed ID: 10615118 [No Abstract] [Full Text] [Related]
13. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424 [TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments. Kachnic LA; Li L; Fournier L; Willers H Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732 [TBL] [Abstract][Full Text] [Related]
18. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons. Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716 [TBL] [Abstract][Full Text] [Related]
19. Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex. Kowal P; Gurtan AM; Stuckert P; D'Andrea AD; Ellenberger T J Biol Chem; 2007 Jan; 282(3):2047-55. PubMed ID: 17082180 [TBL] [Abstract][Full Text] [Related]
20. The Fanconi family adds a fraternal twin. Grompe M; van de Vrugt H Dev Cell; 2007 May; 12(5):661-2. PubMed ID: 17488615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]